Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023. Mike ...
Monday, May 15, 2023 1 min read
Key Takeaway: Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on May 31, 2023. CEO Mike Mahoney is scheduled for a 50-minute Q&A session, which will be available via live webcast. This event allows the company to engage with investors and demonstrate its ongoing commitment to transforming lives through innovative medical solutions.
Market Sentiment Analysis
POSITIVE FACTORS
Boston Scientific will participate in a strategic decisions conference, highlighting its active engagement with investors.
The event provides an opportunity for the CEO to directly address analysts and stakeholders.
The company's commitment to innovation in medical solutions is reinforced through this participation.
Full Press Release Details
Mike Mahoney , chairman and chief executive officer, will participate in a 50-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EDT . A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com .
The replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of each event.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
CONTACTS
Media:
Investors:
Kate Haranis
Lauren Tengler
508-683-6585 (office)
508-683-4479 (office)
Media Relations
Investor Relations
Boston Scientific Corporation
Boston Scientific Corporation
[email protected]
[email protected]
SOURCE Boston Scientific Corporation
21 %
Frequently Asked Questions
When is Mike Mahoney's Q&A session scheduled?
Mike Mahoney's Q&A session is set for approximately 8:00 a.m. EDT.
Where can I watch the live webcast of the session?
The live webcast will be available on Boston Scientific's Investor Relations page.
How long is the Q&A session with Mike Mahoney?
The Q&A session will last for 50 minutes.
When will the webcast replay be available?
The replay of the webcast will be accessible about one hour after the event.
What does Boston Scientific focus on?
Boston Scientific focuses on innovative medical solutions to improve patient health.